Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Yong-Rong Lai"'
Autor:
Xiao-hui Zhang, Jing Chen, Ming-Zhe Han, He Huang, Er-lie Jiang, Ming Jiang, Yong-rong Lai, Dai-hong Liu, Qi-Fa Liu, Ting Liu, Han-yun Ren, Yong-Ping Song, Zi-min Sun, Xiao-wen Tang, Jian-min Wang, De-pei Wu, Lan-ping Xu, Xi Zhang, Dao-bin Zhou, Xiao-jun Huang
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-20 (2021)
Abstract The consensus recommendations in 2018 from The Chinese Society of Hematology (CSH) on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation (allo-HSCT) facilitated the standardization o
Externí odkaz:
https://doaj.org/article/0888f470080e4c5f9d96fc5f09be3e84
Autor:
Yao Chen, Wei-Jun Fu, Lan-Ping Xu, Han-Yun Ren, Yong-Rong Lai, Dai-Hong Liu, Lin Liu, Zi-Min Sun, Yuan-Bin Wu, Xin Wang, Ling-Hui Xia, Ming Jiang, Tong-Lin Hu, Ding-Ming Wan, Xiao-Jun Huang, Yuan-Yuan Ji
Publikováno v:
Chinese Medical Journal, Vol 132, Iss 15, Pp 1765-1772 (2019)
Abstract. Background:. Allogeneic stem-cell transplantation (SCT) is a well-established immunotherapeutic strategy for multiple myeloma (MM) with a potent and often sustained graft-vs.-myeloma effect. This multicenter investigation aimed to analyze t
Externí odkaz:
https://doaj.org/article/844de11142d44cfe9717e73c554b3ed1
Publikováno v:
Current Medical Science. 42:925-931
Gene therapy refers to introducing normal exogenous genes into target cells to correct or compensate for the diseases caused by defective and abnormal genes for the purpose of therapy. It holds out hope of a cure for single-gene genetic diseases such
Autor:
Ying‐Ying Ma, Ze‐liang Wei, Ya‐Jing Xu, Ji‐Min Shi, Hai Yi, Yong‐Rong Lai, Er‐Lie Jiang, San‐Bin Wang, Tao Wu, Lei Gao, Li Gao, Pei‐Yan Kong, Qin Wen, Hai Bai, Yu Li, Yi‐geng Cao, Qiao‐Chuan Li, Zhong‐Ming Zhang, Bei‐Cai Liu, Yi Su, Xiao‐Yu Lai, Xia Ma, Ting‐Ting Cheng, Yi Luo, Xi Zhang, Cheng Zhang
Publikováno v:
Cancer.
Autor:
Wei-da Wang, Fang Hu, Dun-hua Zhou, Robert Peter Gale, Yong-rong Lai, Hong-xia Yao, Chunfu Li, Bing-yi Wu, Zhu Chen, Jian-pei Fang, Sai-juan Chen, Yang Liang
Publikováno v:
Blood Reviews. :101074
Autor:
Ying-Ying, Wu, Bei-Cai, Liu, Lian-Jin, Liu, Shi-Si, Yuan, Jie-Min, Wei, Li-Lin, Wang, Pei-Xi, Wang, Ji-Cong, Liu, Yong-Rong, Lai, Qiao-Chuan, Li
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 30(1)
To analyze the clinical characteristics of bloodstream infection (BSI) in patients treated by hematopoietic stem cell transplantation (HSCT).The clinical characteristics, distribution of pathogenic bacteria causing BSI and drug sensitivity of 910 pat
Autor:
Yong‐Rong Lai, Maria Domenica Cappellini, Yesim Aydinok, John Porter, Zeynep Karakas, Vip Viprakasit, Noppadol Siritanaratkul, Antonis Kattamis, Rongrong Liu, Miguel Izquierdo, Janet Lasher, Sameera Govindaraju, Ali Taher
[No Abstract Available]
Novartis Pharmaceuticals Corporation
This study was sponsored and funded by Novartis Pharmaceuticals Corporation.
Novartis Pharmaceuticals Corporation
This study was sponsored and funded by Novartis Pharmaceuticals Corporation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f9e03417e409465326795ebed716d31
https://hdl.handle.net/11454/75864
https://hdl.handle.net/11454/75864
Autor:
Lan-Ping Xu, Dao-Pei Lu, De-Pei Wu, Er-Lie Jiang, Dai-Hong Liu, He Huang, Zi-Min Sun, Nai-Nong Li, Qi-Fa Liu, Xi Zhang, Yong-Rong Lai, Yong-Ping Song, Xian-Min Song, Si-Xi Liu, Yi-Cheng Zhang, Cheng-Juan Luo, Ling-Hui Xia, Ting Niu, Yu Yu, Xiao-Hui Zhang, Xiao-Wen Tang, Yi Luo, Xiao-Jun Huang
Publikováno v:
Transplantation and Cellular Therapy. 29:136.e1-136.e7
Between 2020 and 2021, 31,525 hematopoietic stem cell transplantations (HSCTs) were reported to the Chinese Blood and Marrow Transplantation Registry Group throughout mainland China. In this report, we describe the activity and current trends for HSC
Autor:
Li Chen, Hong-Ming Zhu, Yan Li, Qi-Fa Liu, Yu Hu, Jian-Feng Zhou, Jie Jin, Jian-Da Hu, Ting Liu, De-Pei Wu, Jie-Ping Chen, Yong-Rong Lai, Jian-Xiang Wang, Juan Li, Jian-Yong Li, Xin Du, Xin Wang, Ming-Zhen Yang, Jin-Song Yan, Gui-Fang Ouyang, Li Liu, Ming Hou, Xiao-Jun Huang, Xiao-Jing Yan, Dan Xu, Wei-Ming Li, Deng-Ju Li, Yin-Jun Lou, Zheng-Jun Wu, Ting Niu, Ying Wang, Xiao-Yang Li, Jian-Hua You, Hui-Jin Zhao, Yú Chen, Yang Shen, Qiu-Sheng Chen, Yù Chen, Jian Li, Bing-Shun Wang, Wei-Li Zhao, Jian-Qing Mi, Kan-Kan Wang, Jiong Hu, Zhu Chen, Sai-Juan Chen, Jun-Min Li
Publikováno v:
Proc Natl Acad Sci U S A
As all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) are widely accepted in treating acute promyelocytic leukemia (APL), deescalating toxicity becomes a research hotspot. Here, we evaluated whether chemotherapy could be replaced or reduced by
Autor:
Jie-Min, Wei, Xiao-Xuan, Lai, Zhong-Ming, Zhang, Lian-Jin, Liu, Rui, Huang, Xia-Yun, Su, Bei-Cai, Liu, Yong-Rong, Lai, Qiao-Chuan, Li
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 27(6)
To investigate the clinical characteristics, etiology and drug susceptibility of bacterial bloodstream infections in acute leukemia(AL) patients.Clinical data, etiology and drug susceptibility of acute leukemia patients with bacterial bloodstream inf